Influence of border-age on survival of sporadic renal cell carcinoma: young adults versus octogenarians

被引:4
作者
Cakici, Mehmet Caglar [1 ]
Kisa, Erdem [2 ]
Yalcin, Mehmet Yigit [2 ]
Efiloglu, Ozgur [1 ]
Yucel, Cem [2 ]
Atis, Gokhan [1 ]
Ilbey, Yusuf Ozlem [2 ]
Yidirim, Asif [1 ]
机构
[1] Istanbul Medeniyet Univ, Goztepe Training & Res Hosp, Dept Urol, Dr Erkin Cd, TR-34722 Istanbul, Turkey
[2] Hlth Sci Univ, Izmir Tepecik Training & Res Hosp, Dept Urol, Izmir, Turkey
关键词
Border-age; Octogenarian; Renal cell carcinoma; Sporadic; Survival; Young adult; INDEPENDENT PROGNOSTIC-FACTOR; OLD PATIENTS; CANCER; TUMORS; STAGE; GRADE;
D O I
10.1007/s11255-020-02552-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose To compare the effects of two border-age groups: young adults and octogenarians on survival of sporadic renal cell carcinoma (RCC). Methods We reviewed the records of 1619 patients that underwent radical or partial nephrectomy due to RCC between January 2004 and December 2018 in two high-volume centers. Patients were divided into two groups based on their age: <= 40 years old (group 1) and >= 80 years old (group 2). We analyzed the demographic, clinical and histological features of the groups and performed univariable and multivariable Cox regression analyses to evaluate predictors associated with survival. Results Median ages of patients were 35.5 years and 82 years in group 1 (n = 90) and group 2 (n = 55), respectively. Radical nephrectomy rate was statistically higher in group 2 (p = 0.004). Median follow-up was 72 (11-192) months in group 1 and 30 months (5-103) in group 2 (p < 0.001). The 5-year (90.2% vs. 80.2%) and 8-year (84.8% vs. 60.2%) overall survivals (OS) of the groups were statistically different (p < 0.001). Patients in group 1 demonstrated a 5 and 10-year cancer-specific survival (CSS) of 90.2% and 84.7%, whereas these rates were 82.4% and 54.9% for group 2 (p < 0.05). We found that higher hemoglobin drop (HR: 1.497), presence of sarcomatoid differentiation (HR: 4.307), high-stage disease (HR: 2.704), and metastasis detected in the follow-up (HR: 12.805) were independent risk factors that shortened OS (p < 0.05). Conclusion Sporadic RCC was associated with a more favorable CSS and OS in young adults compared to the octogenarians. Although two border-age groups had similar pathologies, they have different prognosis and survival rates.
引用
收藏
页码:2087 / 2095
页数:9
相关论文
共 50 条
  • [41] The effect of gender and age on kidney cancer survival: Younger age is an independent prognostic factor in women with renal cell carcinoma
    Rampersaud, Edward N.
    Klatte, Tobias
    Bass, Geoffrey
    Patard, Jean-Jacques
    Bensaleh, Karim
    Boehm, Malte
    Allhoff, Ernst P.
    Cindolo, Luca
    De La Taille, Alexandre
    Mejean, Arnaud
    Soulie, Michel
    Bellec, Laurent
    Bernhard, Jean Christophe
    Pfister, Christian
    Colombel, Marc
    Belldegrun, Arie S.
    Pantuck, Allan J.
    George, Daniel
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (01) : 30.e9 - 30.e13
  • [42] Value of bootstrapping for small series of patients: Application to survival analysis for 26 patients followed for bilateral sporadic renal cell carcinoma
    Hupertan, V
    Roupret, M
    Chauchat, JH
    Bazin, JP
    Jacquemard, A
    Dufour, B
    Mejean, A
    PROGRES EN UROLOGIE, 2003, 13 (06): : 1307 - 1310
  • [43] The age-adjusted Charlson comorbidity index as a predictor of overall survival of surgically treated non-metastatic clear cell renal cell carcinoma
    Ho Won Kang
    Sung Min Kim
    Won Tae Kim
    Seok Joong Yun
    Sang-Cheol Lee
    Wun-Jae Kim
    Eu Chang Hwang
    Seok Ho Kang
    Sung-Hoo Hong
    Jinsoo Chung
    Tae Gyun Kwon
    Hyeon Hoe Kim
    Cheol Kwak
    Seok-Soo Byun
    Yong-June Kim
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 187 - 196
  • [44] Renal cell carcinoma under 35 years of age:: comparison of survival rates for symptomatic and asymptomatic patients
    Zugor, Vahudin
    Fridel, Swetlana
    Lausen, Berthold
    Schott, Guenter E.
    Kuehn, Reinhard
    Labanaris, Apostolos P.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2008, 40 (02) : 289 - 293
  • [45] Renal cell carcinoma under 35 years of age: comparison of survival rates for symptomatic and asymptomatic patients
    Vahudin Zugor
    Swetlana Fridel
    Berthold Lausen
    Günter E. Schott
    Reinhard Kühn
    Apostolos P. Labanaris
    International Urology and Nephrology, 2008, 40 : 289 - 293
  • [46] Sociodemographic disparities in treatment and survival of small localized renal cell carcinoma: surgical resection versus thermal ablation
    Kokabi, Nima
    Xing, Minzhi
    Duszak, Richard, Jr.
    Howard, David H.
    Camacho, Juan C.
    Kim, Hyun S.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2016, 5 (05) : 441 - 452
  • [47] Surgical and functional outcomes of robot-assisted laparoscopic partial nephrectomy for renal cell carcinoma in adolescents and young adults: a propensity score matching study
    Yoshida, Kazuhiko
    Kondo, Tsunenori
    Iizuka, Junpei
    Fukuda, Hironori
    Ishihara, Hiroki
    Kobayashi, Hirohito
    Okumi, Masayoshi
    Ishida, Hideki
    Tanabe, Kazunari
    Takagi, Toshio
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (10) : 1624 - 1631
  • [48] Assessment of survival of patients with metastatic clear cell renal cell carcinoma after radical cytoreductive nephrectomy versus no surgery: a seer analysis
    Xiao, Wen-Jun
    Zhu, Yao
    Dai, Bo
    Zhang, Hai-Liang
    Ye, Ding-Wei
    INTERNATIONAL BRAZ J UROL, 2015, 41 (02): : 288 - 295
  • [49] Sex-specific hormone changes during immunotherapy and its influence on survival in metastatic renal cell carcinoma
    Gennadi Tulchiner
    Renate Pichler
    Hanno Ulmer
    Nina Staudacher
    Andrea Katharina Lindner
    Andrea Brunner
    Bettina Zelger
    Fabian Steinkohl
    Friedrich Aigner
    Wolfgang Horninger
    Martin Thurnher
    Cancer Immunology, Immunotherapy, 2021, 70 : 2805 - 2817
  • [50] THE INFLUENCE OF VENA-CAVAL INVOLVEMENT ON LONG-TERM SURVIVAL IN PATIENTS WITH RENAL-CELL CARCINOMA
    DERIESE, W
    ALLHOFF, E
    STIEF, CG
    SCHLICK, R
    TUMORDIAGNOSTIK & THERAPIE, 1991, 12 (05) : 197 - 200